Abstract
Vaccines produced from chemically “inactivated” Bordetella pertussis have been remarkably effective in diminishing the incidence of whooping cough in the developed world (Hinman and Koplan, 1984). The frequency of adverse vaccine reactions attributed to pertussis immunization, however, has led to a reassessment of the vaccine material and its components (Hinman and Onorato, 1987). In an effort to provide a less reactogenic vaccine, we have focused on a major virulence factor of the Gram-negative etiologic agent. Pertussis toxin (PTX ), also known as lymphocytosis promotion factor (LPF), islet activating protein (IAP), histamine sensitization factor (HSF), and pertussigen (Munoz, 1985), has been shown to be both an important mediator of pertussis disease (Pittman, 1979) and an effective protective element in acellular vaccines that have reduced reactogenicity in pediatric vaccine recipients (Manclark and Cowell, 1984; Robinson et al., 1985; Kallings et al.,1988).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Black, W.J., Munoz, J.J., Peacock, M.G., Schad, P.A., Cowell, J.L., Burchall, J.J., Lim, M., Kent, A., Steinman, L., and Falkow, S., 1988, ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis, Science 240:656.
Brennan, M.J., David, J.L., Kenimer, J.G., and Manclark, C.R., 1988, Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein, J. Biol. Chem. 263:4895.
Brennan, M.J., David, J.L., Kenimer, J.G., and Manclark, C.R., 1988, Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein, J. Biol. Chem. 263:4895.
Burnette, W.N., Cieplak, W., Mar, V.L., Kaljot, K.T., Sato, H., and Keith, J.M., 1988b, Pertussis toxin Sl mutant with reduced enzyme activity and a conserved protective epitope, Science 242:72.
Burns, D.L., Kenimer, J.G., and Manclark, C.R., 1987, Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology, Infect. Immun. 55:24.
Chou, P.Y. and Fasman, G.D., 1978, Prediction of the secondary structure of proteins from their amino acid sequence, Adv. Enzymol. 47:45.
Cieplak, W., Burnette, W.N., Mar, V.L., Kaljot, K.T., Morris, C.F., Chen, K.K., Sato, H. and Keith, J.M., 1988, Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant, Proc. Natl. Acad. Sci. U.S.A. 85:4667.
Devereux, J., Haeberli, P., and Smithies, O., 1984, A comprehensive set of sequence analysis programs for the VAX, Nucl. Acids Res. 12:387.
Gilman, A.G., 1987, G proteins:transducers of receptorgenerated signals, Annu. Rev. Biochem. 56:615.
Goldman, W.E., Klapper, D.G., and Baseman, J.B., 1982, Detection, isolation and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells, Infect. Immun. 36:782.
Hardy, S.J.S., Holmgren, J., Johansson, S., Sanchez, J., and Hirst, T.R., 1988, Coordinated assembly of multisubunit proteins:oligomerization of bacterial enterotoxins in vivo and in vitro, Proc. Natl. Acad. Sci. U.S.A. 85:7109.
Hewlett, E.L., Sauer, K.T., Myers, G.A., Cowell, J.L., and Guerrant, R.L., 1983, Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin, Infect. Immun. 40:1198.
Hewlett, E.L., Urban, M.A., Manclark, C.R. and Wolff, J., 1976, Extracytoplasmic adenylate cyclase of Bordetella pertussis, Proc. Natl. Acad. Sci. U.S.A. 73:1926.
Hinman, A.R. and Koplan, J.P., 1984, Pertussis and pertussis vaccine:reanalysis of benefits, risks, and costs, J. Amer. Med. Assoc. 251:3109.
Hinman, A.R. and Onorato, I.M., 1987, Acellular pertussis vaccines, Pediatr. Infect. Dis. J. 6:341.
Kallings, L.O., and Ad Hoc Group for the Study of Pertussis Vaccines, 1988, Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events, Lancet i:955.
Kaslow, H.R. and Lesikar, D.D., 1987, Sulfhydryl-alkylating reagents inactivate the NAD glycohydrolase of pertussis toxin, Biochemistry 26:3297.
Katada, T., Tamura, M., and Ui, M., 1983, The A protomer of islet-activating protein, pertussis toxin, is an active peptide catalyzing ADP-ribosylation of a membrane protein, Arch. Biochem. Biophys. 224:290.
Katada, T. and Ui, M., 1982, Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein, Proc. Natl. Acad. Sci. U.S.A. 79:3129.
LeDur, A., Caroff, M., Chaby, R. and Szabo, L., 1978, A novel type of endotoxin structure present in Bordetella pertussis, Eur. J. Biochem. 84:579.
LeDur, A., Chaby, R. and Szabo, L., 1980, Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin, J. Bacteriol. 143:78.
Manclark, C.R. and Cowell, J.L., 1984, Pertussis, in:“Bacterial Vaccines,” R. Germanier, ed., Academic Press, Orlando.
Moss, J., Stanley, S.J., Burns, D.L., Hsia, J.A., Yost, D.A., Myers, G.A., and Hewlett, E.L., 1983, Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis (isletactivating protein ) J. Biol. Chem. 258:11879.
Munoz, J.J., 1985, Biological activities of pertussigen (pertussis toxin) in:“Pertussis Toxin,” R.D. Sekura, J. Moss, and M. Vaughn, eds., Academic Press, Orlando.
Neer, E.J. and Clapham, D.E., 1988, Roles of G protein subunits in transmembrane signalling, Nature 333:129.
Okajima, F., Katada, T., and Ui, M., 1985, Coupling of the guanine nucleotide regulatory protein to chemotactic peptide receptors in neutrophil membranes and its uncoupling by islet-activating protein, perti2sis toxin:a possible role of the toxin substrate in Ca -mobilizing receptor mediated signal transduction, J. Biol. Chem. 260:6761.
Pittman, M., 1979, The cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis, Rev. Infect. Dis. 1:401.
Robinson, A., Irons, L.I., and Ashworth, L.A.E., 1985, Pertussis vaccine:present status and future prospects, Vaccine 3:11.
Rogel, A., Farfel, Z., Goldschmidt, S., Shiloach, J., and Hanski, E., 1983, Bordetalla pertussis adenylate cyclase :identification of multiple forms of the enzyme by antibodies, J. Biol. Chem. 263 :13310.
Rosenthal, R. S., Nogami, W., Cookson, B.T., Goldman, W.E., and Folkening, W.J., 1987, Major fragment of soluble peptideoglycan released from growing Bordetella pertussis is tracheal cytotoxin, Infect. Immun. 55 :2117.
Sato, H., Ito, A., Chiba, J., and Sato, Y., 1984. Monoclonal antibody against pertussis toxin :effect on toxin activity and pertussis infections, Infect. Immun. 46 :422.
Sato, H., Sato Y., Ito, A. and Ohishi, I., 1987, Effect of monoclonal antibody to pertussis toxin on toxin activity, Infect. Immun. 55 :909.
Tamura, M., Nogimori, K., Yajima, M., Ase, K., and Ui, M., 1983 A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells, J. Biol. Chem. 258: 6756
Tamura, M., Nogimori, K., Murai, S., Yajima, M., Ito, K., Katada, T., Ui, M., and Ishi, S., 1982, Subunit structure of islet-activating protein, pertussis toxin, in conformi ty with the A-B model, Biochemistry 21 :5516.
Wardlaw, A. C. and Parton, R., 1983 Bordetella pertussis toxins, Pharmacol. Ther. 19:1.
Weiss, A.A. and Hewlett, E. L. 1986, virulence factors of Bordetella pertussis, Annu. Rev. Microbiol. 40 :661.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burnette, W.N. et al. (1989). Developments toward a Recombinant Pertussis Vaccine. In: Atassi, M.Z. (eds) Immunobiology of Proteins and Peptides V. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2046-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2046-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2048-8
Online ISBN: 978-1-4757-2046-4
eBook Packages: Springer Book Archive